Viewing data from:

OSELTAMIVIR PHOSPHATE

ANDA

OSELTAMIVIR PHOSPHATE | A217467 | INVAGEN PHARMACEUTICALS INC

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: TAMIFLU(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 3 NDCs

Highest NADAC/Unit

$0.8064

per ea

Lowest NADAC/Unit

$0.6950

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
76282070445OSELTAMIVIR PHOS 75 MG CAPSULE	$0.8064	EA	Generic	—	2026-08-19
76282070345OSELTAMIVIR PHOS 45 MG CAPSULE	$0.7693	EA	Generic	—	2026-08-19
76282070245OSELTAMIVIR PHOS 30 MG CAPSULE	$0.6950	EA	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 6 NDCs (3 FSS, 3 NC)

Lowest Price

$15.54

Highest Price

$39.95

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
76282-0702-45OSELTAMIVIR PO4 30MG CAP	$15.54	NC	Exelan Pharmaceuticals, Inc.	02/21/2027
76282-0703-45OSELTAMIVIR PO4 45MG CAP	$18.85	NC	Exelan Pharmaceuticals, Inc.	02/21/2027
76282-0704-45OSELTAMIVIR PO4 75MG CAP	$15.61	NC	Exelan Pharmaceuticals, Inc.	02/21/2027
76282-0702-45OSELTAMIVIR PO4 30MG CAP	$39.95	FSS	Exelan Pharmaceuticals, Inc.	09/14/2026
76282-0703-45OSELTAMIVIR PO4 45MG CAP	$39.95	FSS	Exelan Pharmaceuticals, Inc.	09/14/2026
76282-0704-45OSELTAMIVIR PO4 75MG CAP	$39.95	FSS	Exelan Pharmaceuticals, Inc.	09/14/2026

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain23 active DMFs

23 active API suppliers hold Drug Master Files for this ingredient.

CIPLA LTDOSELTAMIVIR PHOSPHATE USP

DMF 215572008

SOLARA ACTIVE PHARMA SCIENCES LTDOSELTAMIVIR PHOSPHATE

DMF 229262009

MSN PHARMACHEM PRIVATE LTDOSELTAMIVIR PHOSPHATE [ROUTE CODE - "OT"]

DMF 238892010

MACLEODS PHARMACEUTICALS LTDOSELTAMIVIR PHOSPHATE

DMF 275332013

MATRIX PHARMACORP PRIVATE LTDOSELTAMIVIR PHOSPHATE USP

DMF 300122015

LUPIN LTDOSELTAMIVIR PHOSPHATE USP

DMF 302532016

HETERO LABS LTDOSELTAMIVIR PHOSPHATE

DMF 304122016

RAKS PHARMA PVT LTDOSELTAMIVIR PHOSPHATE USP

DMF 333732018

LAURUS LABS LTDOSELTAMIVIR PHOSPHATE USP

DMF 337672020

SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTDOSELTAMIVIR PHOSPHATE

DMF 339072020

INNOVARE LABS PRIVATE LTDOSELTAMIVIR PHOSPHATE USP

DMF 347752020

AMPAC FINE CHEMICALS LLCOSELTAMIVIR PHOSPHATE DRUG SUBSTANCE

DMF 352342021

MSN LIFE SCIENCES PRIVATE LTDOSELTAMIVIR PHOSPHATE USP

DMF 354092020

SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTDOSELTAMIVIR PHOSPHATE

DMF 355142021

BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTDOSELTAMIVIR PHOSPHATE

DMF 358762021

AZICO BIOPHORE INDIA PRIVATE LTDOSELTAMIVIR PHOSPHATE

DMF 361832021

CHROMO LABORATORIES INDIA PRIVATE LTDOSELTAMIVIR PHOSPHATE USP

DMF 369712022

ZYDUS LIFESCIENCES LTDOSELTAMIVIR PHOSPHATE USP

DMF 376772022

RUYUAN HEC PHARM CO LTDOSELTAMIVIR PHOSPHATE NON-STERILE BULK DRUG SUBSTANCE

DMF 387162023

ZHEJIANG HUAHAI PHARMACEUTICAL CO LTDOSELTAMIVIR PHOSPHATE USP

DMF 393142023

SHENZHEN HAIBIN PHARMACEUTICAL CO LTDOSELTAMIVIR PHOSPHATE

DMF 406032024

FUJIAN FUKANG PHARMACEUTICAL CO LTDOSELTAMIVIR PHOSPHATE

DMF 421352025

APICORE LLC (A WHOLLY OWNED SUB OF RK PHARMA INC)OSELTAMIVIR PHOSPHATE USP

DMF 432362025

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — EQ 30MG BASE

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Oct 3, 2023

No patent or exclusivity listings for this strength.

#002 — EQ 45MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Oct 3, 2023

#003 — EQ 75MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Oct 3, 2023